IGFBP-1 Expression Promotes Tamoxifen Resistance in Breast Cancer Cells via Erk Pathway Activation
Zheng Yan(New Mexico State University), Kevin D. Houston(New Mexico State University)
Cited by 29
Related Papers
Glucose-dependent GPER1 expression modulates tamoxifen-induced IGFBP-1 accumulation
|Journal of Molecular Endocrinology|2019|9
Insulin-like growth factor binding protein-6 modulates proliferative antagonism in response to progesterone in breast cancer
|Frontiers in Endocrinology|2024|1
Insulin-like growth factor-binding protein-3 is induced by tamoxifen and fulvestrant and modulates fulvestrant response in breast cancer cells
|Frontiers in Oncology|2024|0
IGFBP-6 regulates breast cancer cell cycle progression by promoting exit out of G1
|Journal of Biological Chemistry|2025|0